| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3191943 | Annals of Allergy, Asthma & Immunology | 2012 | 9 Pages |
Abstract
High levels of IgE in the microenvironment in vivo may upregulate the responsiveness of immature MCs to allergens. Omalizumab may inhibit the IgE-mediated responsiveness of not only mature MCs, but also immature MCs.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Yoshimichi MD, PhD, Jun-ichi PhD, Tomomi BSc, Kenji MD, PhD, Noriko BSc, Kazumitsu MD, PhD, Toshiaki MD, PhD, Hirohisa MD, PhD, Chisei MD, PhD,